Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

NCT07172282 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT07172282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07172282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Lead sponsor
Northwell Health
Phase
Phase 1
Overall status
Recruiting
Start date
November 17, 2025
Completion date
November 1, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic